News

Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

March 29, 2017

Members of the GenCure tissue team and volunteers from BioBridge Global will be conducting registration drives for the Donate Life Texas registry during National Donate Life Month in April.

The Donate Life Texas registry allows Texans to register to be organ, eye and tissue donors by completing a form in person or online. A single donor can help save up to eight lives through organ donation, bring sight to more through cornea donation and improve the lives of up to 75 people through tissue donation.

The GenCure tissue center works with organizations across South Texas on posthumous tissue donations, making those tissues available for patients needing everything from bone grafts to ligament repairs.

December 27, 2016

The Texas Cord Blood Bank, a program of nonprofit biomedical organization GenCure and the designated public cord blood bank for the state of Texas, has received a grant to help minimize time between collection of donated umbilical cord blood and preserving those donations so they’re available for patients in need of a transplant.

Learn more about the cord blood donation process.

December 2, 2016

BioBridge Global was one of the sponsors of the 2015 San Antonio Chamber of Commerce Healthcare and Biosciences Economic Impact Study, which was released to the community this fall.

The healthcare and biosciences industry is the fastest-growing sector affecting the economic growth of San Antonio. BioBridge Global is a critical part of that sector, from managing the largest community blood center in South Texas to providing services that enable development of regenerative medicine treatments. BBG is taking the lead in this industry and has forged alliances to help serve patients in San Antonio and around the world.

October 18, 2016

Yvonne Ybarra, director of cellular therapy for GenCure, a subsidiary of the San-Antonio based nonprofit biotech BioBridge Global, has been named chair of the Council Advisory Group (CAG) of the National Marrow Donor Program® (NMDP). She took the role on Oct. 1 and is now a voting member of the NMDP board of directors.

The NMDP’s Be The Match® program facilitates transplants of bone marrow and cord blood for those facing leukemia, lymphoma and other blood cancers; conducts research; provides support and resources for patients; and provides education for physicians. Volunteer donors join the marrow registry in hopes of being a match for and donating to a patient in need of a cure. With a swab of the inside of the cheek, donors join people around the world who want to help save lives.

Funds will help develop capability for large-scale manufacturing of stem cells for research and patient use
October 3, 2016

A four-organization biotech group led by San Antonio-based nonprofit BioBridge Global (BBG) has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC). The funds will enable the development of large-scale manufacturing capabilities for clinical-grade stem cells for research and therapeutic use.   

BBG led a group including the U.S. Army Institute of Surgical Research (USAISR) Coagulation and Blood Research, San Antonio biotech firm StemBioSys and Maryland-based RoosterBio Inc. in submitting the proposal for funding.

Pages